Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.66 CNY
−234.01 M CNY
2.41 B CNY
378.40 M
About SHANGHAI KEHUA BIO
Sector
Industry
Headquarters
Shanghai
Website
Founded
1981
ISIN
CNE000001KC9
FIGI
BBG000Q354F4
Shanghai Kehua Bio-Engineering Co., Ltd. engages in the research, development, manufacture, and marketing of vitro diagnostic devices. Its KHB branded products include application platform and reagent in molecular diagnosis; analysis system, electrolyte analyzer, and pacakging reagent in biochemical diagnosis; kit, microplate reader, and plate washer in immunodiagnosis system; and point-of-care testing (POCT) product. The company was founded in November 1981 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 002022 is 6.67 CNY — it has increased by 0.91% in the past 24 hours. Watch SHANGHAI KEHUA BIO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange SHANGHAI KEHUA BIO stocks are traded under the ticker 002022.
002022 stock has fallen by −7.62% compared to the previous week, the month change is a 0.45% rise, over the last year SHANGHAI KEHUA BIO has showed a −37.66% decrease.
002022 reached its all-time high on Jun 15, 2015 with the price of 64.00 CNY, and its all-time low was 1.75 CNY and was reached on Jul 8, 2005. View more price dynamics on 002022 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
002022 stock is 1.82% volatile and has beta coefficient of 1.19. Track SHANGHAI KEHUA BIO stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI KEHUA BIO there?
Today SHANGHAI KEHUA BIO has the market capitalization of 3.35 B, it has decreased by −6.69% over the last week.
Yes, you can track SHANGHAI KEHUA BIO financials in yearly and quarterly reports right on TradingView.
SHANGHAI KEHUA BIO is going to release the next earnings report on Apr 25, 2025. Keep track of upcoming events with our Earnings Calendar.
002022 net income for the last quarter is −69.68 M CNY, while the quarter before that showed −23.64 M CNY of net income which accounts for −194.71% change. Track more SHANGHAI KEHUA BIO financial stats to get the full picture.
As of Dec 22, 2024, the company has 2.15 K employees. See our rating of the largest employees — is SHANGHAI KEHUA BIO on this list?
Like other stocks, 002022 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI KEHUA BIO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI KEHUA BIO technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI KEHUA BIO stock shows the sell signal. See more of SHANGHAI KEHUA BIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.